Erenumab: a monoclonal antibody for migraine prophylaxis.
- Published in:
- Prescriber, 2019, v. 30, n. 3, p. 38, doi. 10.1002/psb.1750
- By:
- Publication type:
- Article
Works matching IS 09596682 AND DT 2019 AND VI 30 AND IP 3
Results: 7
1
2
Summary of the BSR biological DMARD safety guidelines.
- Published in:
- Prescriber, 2019, v. 30, n. 3, p. 34, doi. 10.1002/psb.1749
- By:
- Publication type:
- Article
3
Implementing the EU Falsified Medicines Directive.
- Published in:
- Prescriber, 2019, v. 30, n. 3, p. 30, doi. 10.1002/psb.1748
- By:
- Publication type:
- Article
4
Cardiovascular risk prediction for primary prevention.
- Published in:
- Prescriber, 2019, v. 30, n. 3, p. 25, doi. 10.1002/psb.1747
- By:
- Publication type:
- Article
5
Emerging UK infections: identifying new threats early.
- Published in:
- Prescriber, 2019, v. 30, n. 3, p. 21, doi. 10.1002/psb.1746
- By:
- Publication type:
- Article
6
Recognition and management of systemic lupus erythematosus.
- Published in:
- Prescriber, 2019, v. 30, n. 3, p. 13, doi. 10.1002/psb.1745
- By:
- Publication type:
- Article
7
The rising tide of biological therapy.
- Published in:
- Prescriber, 2019, v. 30, n. 3, p. 4, doi. 10.1002/psb.1744
- By:
- Publication type:
- Article